IL82944A - Pharmaceutical compositions comprising a ganglioside mixture for prophylaxis of general toxic effects or chronic neurotoxic effects - Google Patents

Pharmaceutical compositions comprising a ganglioside mixture for prophylaxis of general toxic effects or chronic neurotoxic effects

Info

Publication number
IL82944A
IL82944A IL82944A IL8294487A IL82944A IL 82944 A IL82944 A IL 82944A IL 82944 A IL82944 A IL 82944A IL 8294487 A IL8294487 A IL 8294487A IL 82944 A IL82944 A IL 82944A
Authority
IL
Israel
Prior art keywords
effects
prophylaxis
pharmaceutical compositions
general toxic
ganglioside mixture
Prior art date
Application number
IL82944A
Other languages
English (en)
Original Assignee
Fidia Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fidia Spa filed Critical Fidia Spa
Publication of IL82944A publication Critical patent/IL82944A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL82944A 1986-06-30 1987-06-22 Pharmaceutical compositions comprising a ganglioside mixture for prophylaxis of general toxic effects or chronic neurotoxic effects IL82944A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8648203A IT1208751B (it) 1986-06-30 1986-06-30 Possibile uso dei gangliosidi esogeni in malattie tumorali come fattore protettivo contro la neurotossicita' da farmaci antitumorali

Publications (1)

Publication Number Publication Date
IL82944A true IL82944A (en) 1993-04-04

Family

ID=11265194

Family Applications (1)

Application Number Title Priority Date Filing Date
IL82944A IL82944A (en) 1986-06-30 1987-06-22 Pharmaceutical compositions comprising a ganglioside mixture for prophylaxis of general toxic effects or chronic neurotoxic effects

Country Status (16)

Country Link
US (1) US5229373A (fr)
EP (1) EP0251298B1 (fr)
JP (1) JPS6327434A (fr)
AT (1) ATE69381T1 (fr)
AU (1) AU601988B2 (fr)
BE (1) BE1000723A4 (fr)
CA (1) CA1314219C (fr)
DE (2) DE3721562A1 (fr)
DK (1) DK165621C (fr)
ES (1) ES2038621T3 (fr)
FR (1) FR2601248B1 (fr)
GR (2) GR871005B (fr)
IL (1) IL82944A (fr)
IT (1) IT1208751B (fr)
LU (1) LU86930A1 (fr)
ZA (1) ZA874597B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1254280B (it) * 1992-03-13 1995-09-14 Fidia Spa Composizioni farmaceutiche comprendenti monosialoganglioside gm1 o un suo derivato atte al trattamento della malattia di parkinson
US6765087B1 (en) * 1992-08-21 2004-07-20 Vrije Universiteit Brussel Immunoglobulins devoid of light chains
DE4430041A1 (de) 1994-08-24 1996-02-29 Milupa Ag Allergieprotektive Formelnahrung
US5567684A (en) * 1994-09-14 1996-10-22 The Regents Of The University Of California Synthetic ganglioside derivatives
JP2005527467A (ja) 2001-08-29 2005-09-15 ネオーズ テクノロジーズ, インコーポレイテッド 新規な合成ガングリオシド誘導体およびその組成物
EP1603932B1 (fr) 2003-03-06 2012-10-03 Seneb Biosciences Inc. Procedes et compositions pour la synthese enzymatique de gangliosides
WO2009118658A2 (fr) * 2008-03-26 2009-10-01 University Of Oxford Liposomes ciblant le réticulum endoplasmique
WO2010111530A1 (fr) 2009-03-25 2010-09-30 Seneb Biosciences, Inc. Glycolipides en tant que traitement de maladies
US20120148547A1 (en) * 2009-09-01 2012-06-14 Hadasit Medical Reasearch Services & Development Ltd. Combination of vitamin e and beta-glycosphingolipids in compositions and methods for preventing and treating hepatic disorders

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1168205B (it) * 1983-07-21 1987-05-20 Wellcome Italia Derivato di monsialo ganglioside dotato di attivita' antibatterica, antifungina ed antitumorale, composizioni che lo contengono e procedimento per la loro preparazione
IT1182209B (it) * 1985-02-18 1987-09-30 Fidia Farmaceutici Uso terapeutico del monosialoganglioside gm1 e dei suoi derivati in gravi patologie di infarti cerebrali

Also Published As

Publication number Publication date
JPS6327434A (ja) 1988-02-05
DK333787D0 (da) 1987-06-29
IT1208751B (it) 1989-07-10
GR3003790T3 (fr) 1993-03-16
LU86930A1 (fr) 1987-11-11
DK333787A (da) 1987-12-31
BE1000723A4 (fr) 1989-03-21
FR2601248A1 (fr) 1988-01-15
GR871005B (en) 1987-10-23
EP0251298A3 (en) 1988-10-26
EP0251298A2 (fr) 1988-01-07
AU7490887A (en) 1988-01-07
AU601988B2 (en) 1990-09-27
FR2601248B1 (fr) 1989-08-25
DK165621C (da) 1993-06-01
ATE69381T1 (de) 1991-11-15
DE3721562A1 (de) 1988-03-03
DE3774501D1 (de) 1991-12-19
DK165621B (da) 1992-12-28
EP0251298B1 (fr) 1991-11-13
ZA874597B (en) 1988-03-30
ES2038621T3 (es) 1993-08-01
CA1314219C (fr) 1993-03-09
US5229373A (en) 1993-07-20
IT8648203A0 (it) 1986-06-30

Similar Documents

Publication Publication Date Title
OA09772A (en) "mometasone furoate monohydrate, process for making same and pharmaceutical compositions".
WO1994007479A3 (fr) Agents immunopotentialisateurs
FR2694004B1 (fr) Nouvelles 3-(Hydroxybenzylidényl)-indoline-2-ones et 3-(hydroxybenzylidényl)-indoline-2-thiones, leurs procédés de préparation, et les compositions pharmaceutiques qui les contiennent.
IL82944A (en) Pharmaceutical compositions comprising a ganglioside mixture for prophylaxis of general toxic effects or chronic neurotoxic effects
ZA849975B (en) Pharmaceutical preparations containing 1,2-diacylglycero-3-phosphocholines
DK0506772T3 (da) Farmaceutisk præparat indeholdende et phosphosukker
IL89662A0 (en) Pharmaceutical compositions comprising interferon-beta 1
DE3675977D1 (de) Pharmazeutische zusammensetzungen zur verminderung der nebenwirkungen der anti-krebs-chemotherapie und erhoehung der immunitaet.
GB1506664A (en) Antiviral compositions
AU1621888A (en) Pharmaceutical compositions for the treatment of cerebral psycho-organic syndromes
DE69427966D1 (de) Neue o-sulfatierte ganglioside und lyso-ganglioside-derivaten
NZ214449A (en) 13-alpha-alkylgonanes and pharmaceutical compositions
GR3024253T3 (en) High dose vitamin a compositions.